Lyophilization promoting element
11732964 · 2023-08-22
Assignee
Inventors
Cpc classification
F26B5/06
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
International classification
Abstract
A lyophilization promoting element to facilitate the transfer of heat between a lyophilizer and a pre-lyophilization solution. The element includes a base plate with a plurality of apertures. The base plate is made of a thermally conductive material and the apertures are regularly arranged within the base plate, each aperture being sized to receive a pharmaceutical vial container containing a pre-lyophilization solution. A method of lyophilizing includes inserting one or more pharmaceutical vial containers into the plurality of apertures of the lyophilization promoting element and placing the lyophilization promoting element holding the one or more pharmaceutical vial containers on a shelf of a lyophilizer.
Claims
1. A lyophilization promoting element comprising: a base plate comprising a plurality of apertures; the base plate comprising a thermally conductive material; the apertures being regularly arranged within the base plate, and each aperture being sized to receive a pharmaceutical vial container containing a pre-lyophilization solution; wherein the lyophilization promoting element facilitates a transfer of heat between a lyophilizer and the pre-lyophilization solution, and wherein the base plate comprises a hollow polymeric material and a fluid with a negative thermal expansion property.
2. The lyophilization promoting element of claim 1, wherein the base plate comprises aluminum or an oxide of aluminum.
3. The lyophilization promoting element of claim 1, wherein each of the plurality of apertures is cylindrical and has a diameter between 5 and 100 millimeters.
4. The lyophilization promoting element of claim 1, wherein each of the plurality of apertures comprises a circumferential wall and is sized to allow a tolerance of no more than 0.5 millimeters between the circumferential wall and an outer wall of an inserted pharmaceutical vial container.
5. The lyophilization promoting element of claim 1, wherein the base plate has a vertical thickness between 10 and 200 millimeters.
6. The lyophilization promoting element of claim 1, wherein the base plate comprises a surface area and the plurality of apertures occupy more than 50% of the surface area.
7. The lyophilization promoting element of claim 1, wherein at least one of the plurality of apertures extends entirely through a vertical thickness of the base plate.
8. The lyophilization promoting element of claim 1, wherein at least one of the plurality of apertures extends only partially through a vertical thickness of the base plate.
9. The lyophilization promoting element of claim 1, wherein each of the plurality of apertures further comprises a radial groove, the radial groove expanding outwardly from a circumferential wall of each aperture adjacent to a top surface of the base plate.
10. The lyophilization promoting element of claim 9, wherein each radial groove extends at an angle of approximately 45 degrees to a depth of approximately 0.5 to 10 millimeters from the top surface of the base plate down to the circumferential wall of each aperture.
11. A lyophilization promoting element comprising: a base plate comprising a plurality of apertures; the base plate comprising a thermally conductive material; the apertures being regularly arranged within the base plate, and each aperture being sized to receive a pharmaceutical vial container containing a pre-lyophilization solution; wherein the lyophilization promoting element facilitates a transfer of heat between a lyophilizer and the pre-lyophilization solution; wherein each of the plurality of apertures extends only partially through a vertical thickness of the base plate and the base plate further comprises a plurality of protrusions extending up from the base plate into each of the plurality of apertures.
12. The lyophilization promoting element of claim 11, wherein the base plate comprises a thermally conductive material with a thermal conductivity coefficient λ of about 0.1 to about 400.0 [W/mK] at 20° C. at 1 bar and a co-efficient of linear thermal expansion α of about 1 to about 25 [10.sup.−6° C..sup.−1] at normal temperature.
13. The lyophilization promoting element of claim 11, wherein the protrusions are sized and shaped to match an internal bore provided in a bottom of an inserted pharmaceutical vial container, said internal bore extending upwardly into an interior of said inserted pharmaceutical vial container.
14. The lyophilization promoting element of claim 1, wherein the base plate comprises a first portion comprised of a primary material and a second portion comprised of a secondary material, the second portion being located adjacent to a circumferential wall of each of the plurality of apertures.
15. The lyophilization promoting element of claim 1, wherein each of the plurality of apertures extends entirely through a vertical thickness of the base plate and further comprises a radial ridge, the radial ridge extending inwardly from a circumferential wall of each aperture adjacent to a bottom surface of the base plate.
16. The lyophilization promoting element of claim 15, wherein each radial ridge extends at an angle of approximately 45 degrees to a height of approximately 0.5 to 6 millimeters from the bottom surface of the base plate up into each aperture to meet the circumferential wall of each aperture.
17. The lyophilization promoting element of claim 1, wherein each of the plurality of apertures further comprises at least one side channel that permits the passage of air, said side channel having a width no greater than 10% of a perimeter of the aperture.
18. A method of lyophilization comprising steps of: providing a lyophilization promoting element comprising: a base plate comprising a plurality of apertures, the base plate comprising a thermally conductive material; the apertures being regularly arranged within the base plate; wherein the lyophilization promoting element facilitates the transfer of heat between a lyophilizer and the pre-lyophilization solution; providing one or more pharmaceutical vial containers containing a pre-lyophilization solution, the one or more pharmaceutical vial containers being half stoppered; inserting the one or more pharmaceutical vial containers into the plurality of apertures of the lyophilization promoting element; providing a tray; placing the lyophilization promoting element holding the one or more pharmaceutical vial containers on the tray; placing the tray and the lyophilization promoting element holding the one or more pharmaceutical vial containers on the shelf of the lyophilizer; removing the tray from between the shelf of the lyophilizer and the lyophilization promoting element, leaving the lyophilization promoting element holding the one or more pharmaceutical vial containers on the shelf of the lyophilizer; closing a door to the lyophilizer and initiating the lyophilization process, said lyophilization process comprising the steps of freezing, primary drying, and secondary drying; reinserting the tray between the lyophilizer shelf and the lyophilization promoting element and removing the tray and the lyophilization promoting element holding the one or more pharmaceutical vial containers from the lyophilizer upon completion of the lyophilization process; and fully stoppering and sealing the one or more pharmaceutical vial containers.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
DETAILED DESCRIPTION
(23) Presently described herein is an efficient solution for an overall improved lyophilization process with efficient heat transfer, less vial-to-vial variation in the drying process, less risk of product spillage during transfer, and tracking of individual vial position in the lyophilizer.
(24) The term “lyophilization” (also known as freeze-drying, lyophilisation, or cryodesiccation) means a process of removal water or other solvents by freezing a material containing water and/or other solvents followed by reducing the surrounding pressure to allow the frozen water and/or other solvents in the material to sublimate directly from the solid phase to the gas phase.
(25) As contemplated herein, unless otherwise noted, lyophilization is meant to involve three phases: freezing, primary drying, and secondary drying.
(26) Lyophilization is performed within a lyophilizer. A variety of lyophilizers are commercially available and known in the art. The lyophilizer will have a lyophilizing chamber in which containers of product to be lyophilized are placed. The lyophilizing chamber contains one or more shelves on which the containers are placed. Typically, a plurality of shelves is used in the lyophilizing chamber during the lyophilization process.
(27) The lyophilizer is used to remove solvent from a pharmaceutical product solution. As used herein, “product solution” is meant to refer to any liquid mixture containing one or more pharmaceutical solids and a pharmaceutically acceptable solvent. The solid may be fully dissolved or dispersed within the solvent.
(28) Processes and apparatus for filling and loading vials into and out of a typical commercial, production-scale lyophilizer are described in. e.g., U.S. Pat. Nos. 9,522,752 and 10,781,003. It is envisioned that the elements, systems, and methods described herein may be used in conjunction with such processes and apparatus.
(29)
(30) To initiate the lyophilization process, the containers 12 are loaded into the lyophilizer upon the several shelves 14, and the door 22 to the lyophilizer is closed to create an enclosed space. The three steps of the lyophilization process are then performed—freezing, primary drying, and secondary drying—and the containers 12 are then removed from the lyophilizer and sealed for packaging and transport.
(31) The present invention improves upon the lyophilization process by encompassing the plurality of containers 12 with a lyophilization promoting element 24. As depicted in
(32) The height/depth of the pockets 26 may be about 5 mm to about 100 mm, or more preferably from about 10 mm to 80 mm and the width or diameter typically will be about 5 mm to about 30 mm, more preferably about 10 mm to about 25 mm. Most preferably, the height is about 20 mm to about 75 mm and diameter is about 15 mm to about 48 mm. Preferably, the pocket size is adapted to the size of container 12 and will allow a tolerance of about 0.05 mm to about 0.5 mm between the circumferential wall 30 of the pocket 26 and outer wall of container 12. The thickness of the element 24 is preferably about 10 mm to 200 mm, and more preferably between 20 mm and 100 mm. The area of the element 24 occupied by the pockets 26 is preferably more than 20% of total area when observed from above, more preferably more than 50%, and even more preferably more than 80%.
(33) In some preferable embodiments, the pockets 26 extend through the entire thickness of the element 24 such that a bottom edge of the container 12 is visible and accessible when the container 12 is installed within the element 24. In other preferable embodiments, the pockets 26 extend only partially through the thickness of the element 24, creating a lower surface of the pockets 26 upon which the bottom edge of the containers 12 may rest when the containers are installed within the element 24. In preferable embodiments, the pockets 26 are sized to provide a snug fit for containers 12 contained therein such that the containers 12 do not fall through the element 24 when the element 24 is lifted, regardless of which preferable embodiment is used.
(34) The container 12 will typically be a vial used to contain a liquid formulation and may be glass or glass-like vials or other suitably sterile transparent vials that are commercially available from various suppliers, including Nuova Ompi, Schott AG, or Daikyo Seiko, Ltd, for example. Pharmaceutical containers made from tubular glass are commercially available in a range of different sizes with dimensions according to the DIN/ISO 8362-1 standard. Molded glass vials are commercially available in a range of different sizes with dimensions according to the DIN/ISO 8362-4 standard. Particularly suitable glass containers are those described in 36 USP <660>/EP 3.2.1 Glass Containers for Pharmaceutical Use (2017). Glass has traditionally been the only choice for container material but problems with glass breakage, delamination, particulates due to glass-on-glass collisions, and stability of some products resulted in development and usage of suitable polymeric materials. One example of such polymeric material is TOPAS® cyclic olefin polymer. Vials made of polymeric materials are commercially available in size ranges and dimensions that typically closely mimic those of glass vials. Polymeric materials are significantly less scratch resistant than glass and existing aseptic processing equipment has not been redesigned to mitigate the risks of scratching. Scratched surfaces of containers are a serious concern for the perceived quality of the product, but also severely limits the inspection of the containers for particulates. Such inspection is typically a regulated requirement for good manufacturing practice. All such containers 12 are envisioned for use with the element 24. In some embodiments, the pocket 26 is adapted to contain a size 2R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R or 100R injection vial. The container 12 may further include a suitable stopper, such as commercially available elastomeric stoppers, e.g., those made or distributed by Daikyo Seiko, Ltd or West Pharmaceutical Services, Inc.
(35) It is desirable that the pocket 26 have a depth that allows it to envelope the side wall portion of container 12 containing the solution 16 at least up to the height of the solution. In some embodiments, the pocket will have a depth sufficient to envelope 25%, more preferably 50% to 75% of the height (excluding neck) of a vial. In preferable embodiments, the depth of the pocket 26 is sufficient to surround the body of a vial but does not cover the vial neck. In certain embodiment, the depth of the pocket 26 is substantially similar to a height (excluding neck) of a standard size injection vial. In other embodiment, the depth of the pocket 26 is substantially similar to the height (including neck) of a vial.
(36) In some embodiments, the element 24 of the present invention may be made up of polymeric material. The polymeric material can be hollow or filled with fluid having negative thermal expansion property, i.e., the fluid expands upon cooling, which can help to improve intimate contact of the element 24 and containers 12 placed within.
(37) Referring now to
(38) In the preferable embodiment depicted in
(39) As depicted in
(40)
(41) The lyophilization process then occurs, and the element 24 and containers 12 are removed from the lyophilizer once complete, either by sliding tray 32 between the element 24 and lyophilizer shelf 14 or by simply removing the element 24 with inserted containers 12 on its own where no tray 32 is employed. As noted, preferable embodiments of the lyophilization promoting element 24 employ pockets 26 sized to accommodate containers 12 snugly such that they remain removably held within the element 24 when the element 24 is being removed, manipulated, and/or transferred even in preferable embodiments in which the pockets 26 extend through the entire thickness of the element 24.
(42) Referring next to
(43) Various shapes are available for the internal bore 34, including but not limited to those depicted in
(44) Referring now to
(45) Referring next to
(46) Referring now to
(47) Notably, while some preferable embodiments of the element 24 employ a plurality of pockets 26 all of which either extend entirely through the element's 24 thickness or do not, other embodiments may employ a plurality of both. In other words, some embodiments of the element 24 may include a plurality of pockets 26 that extend through the entire thickness of the element and a plurality of pockets 26 that do not, or any combination thereof, as those of skill in the art will appreciate.
(48)
(49) Furthermore, in the preferable embodiments of the element 24 depicted in
(50) In some preferable embodiments, the pockets 26 have side channels to permit air displacement while inserting the containers 12 into the pockets 26. The side channel feature is particularly useful in preferable embodiments in which the pockets 26 do not extend through the entire thickness of the element 24, creating a lower surface of the pockets 26 upon which the bottom 48 of the containers 12 may rest when the containers 12 are installed within the element 24. Such side channels preferably have a width of about 1% to 10% of the total perimeter of the pockets 26. The side channels may be cylindrical or cubical or any other shape that can assist with the passage of air, as will be understood by those of skill in the art.
(51) In some embodiments, the pockets 26 are numbered by engraving, printing, or embossing to locate the position of a container 12 on the shelf before lyophilization, and also after lyophilization. Such numbering can help in sampling or investigation.
(52) Referring lastly to
(53) While the present invention has been described with reference to particular embodiments and arrangements of parts, features, and the like, it is not limited to these embodiments or arrangements. Indeed, modifications and variations will be ascertainable to those of skill in the art, all of which are inferentially and inherently included in these teachings.